Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

被引：0

作者：

Zha, Jie ^{[1
,2
,3
]}

Chen, Qinwei ^{[1
,2
,3
]}

Zhang, Wei ^{[4
]}

Jing, Hongmei ^{[5
]}

Ye, Jingjing ^{[6
]}

Yu, Haifeng ^{[7
,8
]}

Yi, Shuhua ^{[9
]}

Li, Caixia ^{[10
]}

Zheng, Zhong ^{[11
]}

Xu, Wei ^{[12
]}

Li, Zhifeng ^{[1
,2
]}

Ping, Lingyan ^{[13
]}

He, Xiaohua ^{[14
,15
,16
]}

Zhang, Liling ^{[17
]}

Xie, Ying ^{[18
]}

Chen, Feili ^{[19
]}

Sun, Xiuhua ^{[20
]}

Su, Liping ^{[21
]}

Zhang, Huilai ^{[22
]}

Lin, Zhijuan ^{[1
,2
]}

Yang, Haiyan ^{[23
]}

Zhao, Weili ^{[11
]}

Qiu, Lugui ^{[9
]}

Li, Zhiming ^{[15
,16
,24
]}

Song, Yuqin ^{[25
]}

Xu, Bing ^{[1
,2
]}

机构：

[1] Xiamen Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Xiamen, Peoples R China

[2] Xiamen Univ, Inst Hematol, Sch Med, Xiamen, Peoples R China

[3] Key Lab Xiamen Diag & Treatment Hematol Malignanc, Xiamen, Peoples R China

[4] Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China

[5] Peking Univ Third Hosp, Dept Hematol, Lymphoma Res Ctr, Beijing, Peoples R China

[6] Shandong Univ, Qilu Hosp, Dept Hematol, Cheeloo Coll Med, Jinan, Peoples R China

[7] Univ Chinese Acad Sci, Canc Hosp, Dept Lymphoma, Zhejiang Canc Hosp, Hangzhou, Peoples R China

[8] Chinese Acad Sci, Inst Canc & Basic Med IBMC, Dept Lymphoma, Hangzhou, Peoples R China

[9] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China

[10] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou, Peoples R China

[11] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, State Key Lab Med Genom, Ruijin Hosp,Shanghai Inst Hematol,Sch Med, Shanghai, Peoples R China

[12] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China

[13] Peking Univ, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst,Beijing Canc Hosp, Beijing, Peoples R China

[14] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou, Peoples R China

[15] State Key Lab Oncol South China, Guangzhou, Peoples R China

[16] Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China

[17] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China

[18] Fujian Med Univ, Fujian Prov Hosp, Dept Hematol, Shengli Clin Med Coll, Fuzhou, Peoples R China

[19] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Lymphoma Div, Guangzhou, Peoples R China

[20] Dalian Med Univ, Hosp 2, Dalian, Peoples R China

[21] Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp, Canc Hosp,Chinese Acad Med Sci, Taiyuan, Peoples R China

[22] Tianjin Med Univ, Dept Lymphoma, Canc Hosp, Tianjin, Peoples R China

[23] Zhejiang Canc Hosp, Hangzhou, Peoples R China

[24] Sun Yat Sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China

[25] Peking Univ, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-182812

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] POD24 in follicular lymphoma: time to be "wise"
Leonard, John P.
[J]. BLOOD, 2022, 139 (11) : 1609 - 1610
[2] External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse
Boyne, Devon J.
Chua, Neil
Owen, Carolyn
Joe-Uzuegbu, Ofodile
Shakir, Huma
Gogna, Priyanka
Jarada, Tamer N.
Brenner, Darren R.
Elia-Pacitti, Julia
Ewara, Emmanuel M.
Cheung, Winson Y.
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (09): : e277 - e285
[3] Evaluation of the Different Stratification Models for POD24 Prediction in Patients with Follicular Lymphoma
Wu, Wei
Bruscaggin, Alessio
Valera, Alexandra
Flospergher, Elena
Bonfiglio, Ferdinando
Spina, Valeria
Terzi-Di-Bergamo, Lodovico
Moccia, Alden
Moia, Riccardo
Ruffini, Alessia
Stathis, Anastasios
Faderl, Martin
Koch, Ricardo
Forestieri, Gabriela
Pini, Katia
Condoluci, Adalgisa
Pirosa, Maria Cristina
Gerber, Bernhard
Gillessen, Silke
Stussi, Georg
Ghielmini, Michele
Cavalli, Franco
Luminari, Stefano
Boldorini, Renzo
Mazzucchelli, Luca
Gaidano, Gianluca
Rossi, Davide
Zucca, Emanuele
[J]. BLOOD, 2020, 136
[4] REAL-LIFE IMPACT OF THE POD24 INDICATOR IN PATIENTS WITH FOLLICULAR LYMPHOMA
Noguerales Blanca, De Felipe
de Abia Alejandro, Luna
Arribas Ana, Lario
Rumschisky Pablo, Palomo
Jarreta Lucia, Bolea
Palomares Juan, Marquet
Moro Fernando, Martin
Cosio Monica, Garcia
Puente Pilar, Herrera
Francisco Javier, Lopez Jimenez
[J]. HAEMATOLOGICA, 2021, 106 (10) : 49 - 49
[5] Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis
Fenghua Gao
Tingting Zhang
Hengqi Liu
Wei Li
Xianming Liu
Lihua Qiu
Lanfang Li
Shiyong Zhou
Zhengzi Qian
Sitong Dong
Sai Zhao
Xianhuo Wang
Huilai Zhang
[J]. Annals of Hematology, 2022, 101 : 2383 - 2392
[6] Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis
Fenghua Gao
Tingting Zhang
Hengqi Liu
Wei Li
Xianming Liu
Lihua Qiu
Lanfang Li
Shiyong Zhou
Zhengzi Qian
Sitong Dong
Sai Zhao
Xianhuo Wang
Huilai Zhang
[J]. Annals of Hematology, 2022, 101 : 2817 - 2817
[7] Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis
Gao, Fenghua
Zhang, Tingting
Liu, Hengqi
Li, Wei
Liu, Xianming
Qiu, Lihua
Li, Lanfang
Zhou, Shiyong
Qian, Zhengzi
Dong, Sitong
Zhao, Sai
Wang, Xianhuo
Zhang, Huilai
[J]. ANNALS OF HEMATOLOGY, 2022, 101 (11) : 2383 - 2392
[8] Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma
Laura Alaimo
Henrique A. Lima
Zorays Moazzam
Yutaka Endo
Jason Yang
Andrea Ruzzenente
Alfredo Guglielmi
Luca Aldrighetti
Matthew Weiss
Todd W. Bauer
Sorin Alexandrescu
George A. Poultsides
Shishir K. Maithel
Hugo P. Marques
Guillaume Martel
Carlo Pulitano
Feng Shen
François Cauchy
Bas Groot Koerkamp
Itaru Endo
Minoru Kitago
Timothy M. Pawlik
[J]. Annals of Surgical Oncology, 2023, 30 : 5406 - 5415
[9] External Validation of the FLIPI Risk Score Measured at Initial Diagnosis and POD24 Among Previously Treated Individuals with Progressed Follicular Lymphoma in Alberta, Canada
Owen, Carolyn
Chua, Neil
Boyne, Devon
Joe-Uzuegbu, Ofodile
Shakir, Huma
Gonga, Priyanka
Brenner, Darren
Elia-Pacitti, Julia
Ewara, Emmanuel
Cheung, Winson Y.
[J]. BLOOD, 2022, 140 : 8024 - 8025
[10] Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status
Merryman, Reid W.
Belada, David
Sureda, Anna
Leppa, Sirpa
Vermaat, Joost S. P.
Holte, Harald
Hutchings, Martin
Lugtenburg, Pieternella
de Vos, Sven
Abrisqueta, Pau
Nijland, Marcel
Christensen, Jacob Haaber
Wahlin, Bjorn E.
Linton, Kim M.
Wang, Liwei
Abbas, Aqeel
Rana, Ali
Quadri, Syed
Falchi, Lorenzo
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S454 - S454

← 1 2 3 4 5 →